Evidence map›Paper›PMID 17157995›Full record

ArticleNeuroscience2007

Integrins regulate opioid receptor signaling in trigeminal ganglion neurons.

K A Berg, G Zardeneta, K M Hargreaves, W P Clarke, S B Milam

Open access · greenAbstract read
In one paragraph

Article in Neuroscience, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Regulation of κ-opioid receptor signaling in peripheral sensory neurons in vitro and in vivo.The Journal of pharmacology and experimental therapeutics · 2011
    Article
  14. Orofacial pain.Pain · 2011
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Peripheral mechanisms of pain and analgesia.Brain research reviews · 2009
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

K A BergDepartment of Pharmacology, University of Texas Health Science Center, San Antonio, TX 78229-3900, USA.
G Zardeneta
K M Hargreaves
W P Clarke
S B Milam
The University of Texas Health Science Center at San Antonio · US

Funding

Peripheral Opioid Regulation: Nociceptors & Pain in ManP01DA016719 · NIDA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI HARGREAVES, KENNETH M · 2003 to 2007
$3.7M
Integrins and mechanoreception in the inflames TMJ.R01DE015371 · NIDCR · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI JESKE, NATHANIEL AARON · 2003 to 2006
$1.5M
NIDA NIH HHS P01 DA016719NIDA NIH HHS P01 DA016719-010002NIDCR NIH HHS R01 DE015371NIDCR NIH HHS R01 DE015371-04
6 · The paper itself

Abstract

The binding of integrins to the extracellular matrix results in focal organization of the cytoskeleton and the genesis of intracellular signals that regulate vital neuronal functions. Recent evidence suggests that integrins modulate G-protein-coupled receptor (GPCR) signaling in hippocampal neurons. In this study we evaluated the hypothesis that integrins regulate the mu opioid receptor in rat trigeminal ganglion neurons. For these studies, primary cultures of adult rat trigeminal ganglion neurons were used to demonstrate the colocalization of beta1 and beta3 integrins with mu opioid receptor in caveolin-1-rich membrane fractions, and at focal adhesions sites generated by integrin ligand binding. Furthermore, we show that the mu opioid receptor agonist, DAMGO ([D-Ala(2),N-MePhe(4),Gly-ol(5)]enkephalin), inhibits cyclic AMP (cAMP) accumulation in response to prostaglandin E2 (PGE(2)) stimulation in bradykinin-primed, but not unprimed, cultured trigeminal ganglia neurons. Application of soluble GRGDS (Gly-Arg-Gly-Asp-Ser) peptides that bind specific integrins (i.e. RGD-binding integrins) completely abolished the DAMGO effect in bradykinin-primed trigeminal ganglia neurons, but did not alter bradykinin-mediated hydrolysis of phosphatidylinositol. Likewise, monospecific anti-beta1 and anti-beta3 integrin subunit antibodies blocked this DAMGO effect in bradykinin-primed trigeminal ganglia neurons. Indeed, application of anti-beta1 integrin subunit actually reversed DAMGO signaling, resulting in increased cAMP accumulation in these cells. This suggests that the relative amounts of specific activated integrins at focal adhesions may govern signaling by the mu opioid receptor, perhaps by altering interactions with G proteins (e.g. Galphai vs. Galphas). Collectively, these data provide the first evidence that specific integrins regulate opioid receptor signaling in sensory neurons.

Indexed as

Analgesics, OpioidAnimalsAntibodiesBradykininCells, CulturedCyclic AMPDinoprostoneEnkephalin, Ala(2)-MePhe(4)-Gly(5)-Focal AdhesionsIntegrin beta1Integrin beta3IntegrinsMaleNeurons, AfferentOligopeptidesRatsAnalgesics, OpioidAntibodiesBradykininCyclic AMPDinoprostoneEnkephalin, Ala(2)-MePhe(4)-Gly(5)-glycyl-arginyl-glycyl-aspartyl-serineIntegrin beta1Integrin beta3IntegrinsOligopeptidesReceptors, G-Protein-CoupledReceptors, Opioid, mu

Identifiers

PMID17157995
PMCPMC1853383
OpenAlexW1980661822

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.